Published in Mol Imaging Biol on October 01, 2014
CEST signal at 2ppm (CEST@2ppm) from Z-spectral fitting correlates with creatine distribution in brain tumor. NMR Biomed (2014) 1.06
Highly accelerated chemical exchange saturation transfer (CEST) measurements with linear algebraic modeling. Magn Reson Med (2015) 0.89
Assessment of lymphatic impairment and interstitial protein accumulation in patients with breast cancer treatment-related lymphedema using CEST MRI. Magn Reson Med (2015) 0.81
Imaging metabolic heterogeneity in cancer. Mol Cancer (2016) 0.80
Molecular magnetic resonance imaging in cancer. J Transl Med (2015) 0.79
CEST-MRI detects metabolite levels altered by breast cancer cell aggressiveness and chemotherapy response. NMR Biomed (2016) 0.75
Magnetization Transfer MRI Contrast May Correlate with Tissue Redox State in Prostate Cancer. Adv Exp Med Biol (2016) 0.75
Optical redox imaging indices discriminate human breast cancer from normal tissues. J Biomed Opt (2016) 0.75
Assessment of the Tumor Redox Status in Head and Neck Cancer by 62Cu-ATSM PET. PLoS One (2016) 0.75
Progress in the clinical detection of heterogeneity in breast cancer. Cancer Med (2016) 0.75
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med (2012) 44.56
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell (2005) 9.18
Assessment of glycosaminoglycan concentration in vivo by chemical exchange-dependent saturation transfer (gagCEST). Proc Natl Acad Sci U S A (2008) 4.43
NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal (2008) 4.23
MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST). Proc Natl Acad Sci U S A (2007) 3.97
Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol (2007) 3.90
Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med (2010) 3.62
Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res (1978) 3.54
Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest (2013) 3.46
Magnetic resonance imaging of glutamate. Nat Med (2012) 3.17
Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res (2000) 3.14
Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-Gluco-RGD autoradiography. J Nucl Med (2008) 2.22
Metapopulation dynamics and spatial heterogeneity in cancer. Proc Natl Acad Sci U S A (2002) 2.17
Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging. Clin Cancer Res (2007) 2.08
High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed (2002) 2.05
In vivo mapping of brain myo-inositol. Neuroimage (2010) 2.02
Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia. PLoS Genet (2011) 1.90
Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat. Cancer Res (2005) 1.81
Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits. FASEB J (2008) 1.67
Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer. Cancer Res (2013) 1.50
Combined vascular and extracellular pH imaging of solid tumors. NMR Biomed (2002) 1.44
Quantitative magnetic resonance and optical imaging biomarkers of melanoma metastatic potential. Proc Natl Acad Sci U S A (2009) 1.38
Quantitative mitochondrial redox imaging of breast cancer metastatic potential. J Biomed Opt (2010) 1.36
Imaging in vivo extracellular pH with a single paramagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent. Mol Imaging (2012) 1.34
Exchange rates of creatine kinase metabolites: feasibility of imaging creatine by chemical exchange saturation transfer MRI. NMR Biomed (2012) 1.34
Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor status. Cancer Res (2010) 1.28
High spatial resolution readout of 3-D metabolic organ structure: an automated, low-temperature redox ratio-scanning instrument. Anal Biochem (1985) 1.24
Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype. Br J Cancer (2010) 1.23
The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas. Cancer Res (2006) 1.15
Predicting melanoma metastatic potential by optical and magnetic resonance imaging. Adv Exp Med Biol (2007) 1.12
Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy. J Magn Reson (1998) 1.10
MITOCHONDRIAL REDOX IMAGING FOR CANCER DIAGNOSTIC AND THERAPEUTIC STUDIES. J Innov Opt Health Sci (2009) 1.08
Histological basis of MR/optical imaging of human melanoma mouse xenografts spanning a range of metastatic potentials. Adv Exp Med Biol (2009) 0.99
Spatial and temporal expression of angiogenic molecules during tumor growth and progression. Oncol Res (1998) 0.99
Characterizing the metabolic heterogeneity in human breast cancer xenografts by 3D high resolution fluorescence imaging. Springerplus (2013) 0.98
Imaging mitochondrial redox potential and its possible link to tumor metastatic potential. J Bioenerg Biomembr (2012) 0.97
The determination of the redox states and phosphorylation potential in living tissues and their relationship to metabolic control of disease phenotypes. Biochem Mol Biol Educ (2006) 0.94
Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model. Biomark Res (2013) 0.92
Review: biologic heterogeneity of cancer metastases. Breast Cancer Res Treat (1987) 0.91
Tumor microvasculature observed using different contrast agents: a comparison between Gd-DTPA-Albumin and B-22956/1 in an experimental model of mammary carcinoma. MAGMA (2008) 0.85
REDOX IMAGING OF THE p53-DEPENDENT MITOCHONDRIAL REDOX STATE IN COLON CANCER EX VIVO. J Innov Opt Health Sci (2013) 0.85
Blood oxygen level dependent angiography (BOLDangio) and its potential applications in cancer research. NMR Biomed (2012) 0.81
Characterizing prostate tumor mouse xenografts with CEST and MT-MRI and redox scanning. Adv Exp Med Biol (2013) 0.80
On the surviving fraction in irradiated multicellular tumour spheroids: calculation of overall radiosensitivity parameters, influence of hypoxia and volume effects. Phys Med Biol (2005) 0.80
Redox imaging of human breast cancer core biopsies: a preliminary investigation. Acad Radiol (2013) 0.80
Magnetic resonance imaging of glutamate. Nat Med (2012) 3.17
T1rho relaxation mapping in human osteoarthritis (OA) cartilage: comparison of T1rho with T2. J Magn Reson Imaging (2006) 2.62
Sodium and T1rho MRI for molecular and diagnostic imaging of articular cartilage. NMR Biomed (2006) 2.48
23Na MRI accurately measures fixed charge density in articular cartilage. Magn Reson Med (2002) 2.44
Proteoglycan depletion-induced changes in transverse relaxation maps of cartilage: comparison of T2 and T1rho. Acad Radiol (2002) 2.17
In vivo mapping of brain myo-inositol. Neuroimage (2010) 2.02
Assessment of human disc degeneration and proteoglycan content using T1rho-weighted magnetic resonance imaging. Spine (Phila Pa 1976) (2006) 2.01
Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. Clin Infect Dis (2012) 2.00
3D-T1rho-relaxation mapping of articular cartilage: in vivo assessment of early degenerative changes in symptomatic osteoarthritic subjects. Acad Radiol (2004) 1.96
Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma. Clin Cancer Res (2011) 1.84
Artifacts in T1 rho-weighted imaging: compensation for B(1) and B(0) field imperfections. J Magn Reson (2007) 1.77
Artifacts in T(1rho)-weighted imaging: correction with a self-compensating spin-locking pulse. J Magn Reson (2003) 1.69
Altered glutathione redox state in schizophrenia. Dis Markers (2006) 1.67
Reduction of residual dipolar interaction in cartilage by spin-lock technique. Magn Reson Med (2004) 1.61
Quantification of cartilage biomechanical and biochemical properties via T1rho magnetic resonance imaging. Magn Reson Med (2005) 1.61
In vivo quantification of human lumbar disc degeneration using T(1rho)-weighted magnetic resonance imaging. Eur Spine J (2006) 1.58
Knee articular cartilage damage in osteoarthritis: analysis of MR image biomarker reproducibility in ACRIN-PA 4001 multicenter trial. Radiology (2011) 1.58
Proteoglycan loss in human knee cartilage: quantitation with sodium MR imaging--feasibility study. Radiology (2004) 1.57
In vivo proton MR three-dimensional T1rho mapping of human articular cartilage: initial experience. Radiology (2003) 1.51
Serial changes in the white matter diffusion tensor imaging metrics in moderate traumatic brain injury and correlation with neuro-cognitive function. J Neurotrauma (2009) 1.50
Correlation of T1rho with fixed charge density in cartilage. J Magn Reson Imaging (2004) 1.49
Chemical exchange saturation transfer magnetic resonance imaging of human knee cartilage at 3 T and 7 T. Magn Reson Med (2011) 1.43
T1rho-prepared balanced gradient echo for rapid 3D T1rho MRI. J Magn Reson Imaging (2008) 1.42
Quantitative magnetic resonance and optical imaging biomarkers of melanoma metastatic potential. Proc Natl Acad Sci U S A (2009) 1.38
In vivo measurement of T1rho dispersion in the human brain at 1.5 tesla. J Magn Reson Imaging (2004) 1.38
Quantitative mitochondrial redox imaging of breast cancer metastatic potential. J Biomed Opt (2010) 1.36
Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. Schizophr Bull (2003) 1.34
Exchange rates of creatine kinase metabolites: feasibility of imaging creatine by chemical exchange saturation transfer MRI. NMR Biomed (2012) 1.34
Method for high-resolution imaging of creatine in vivo using chemical exchange saturation transfer. Magn Reson Med (2013) 1.31
Three-dimensional T1rho-weighted MRI at 1.5 Tesla. J Magn Reson Imaging (2003) 1.28
Detection of changes in articular cartilage proteoglycan by T(1rho) magnetic resonance imaging. J Orthop Res (2005) 1.27
Focal Wallerian degeneration of the corpus callosum in large middle cerebral artery stroke: serial diffusion tensor imaging. J Magn Reson Imaging (2006) 1.26
In vivo quantification of T1rho using a multislice spin-lock pulse sequence. Magn Reson Med (2004) 1.26
Quantifying sodium in the human wrist in vivo by using MR imaging. Radiology (2002) 1.24
Microbial diversity in saliva of oral squamous cell carcinoma. FEMS Immunol Med Microbiol (2011) 1.23
Compensation for spin-lock artifacts using an off-resonance rotary echo in T1rhooff-weighted imaging. Magn Reson Med (2007) 1.20
Method for reduced SAR T1rho-weighted MRI. Magn Reson Med (2004) 1.18
On B1 inhomogeneity correction of in vivo human brain glutamate chemical exchange saturation transfer contrast at 7T. Magn Reson Med (2012) 1.15
Sodium magnetic resonance imaging of proteoglycan depletion in an in vivo model of osteoarthritis. Acad Radiol (2004) 1.14
In vivo measurement of plaque burden in a mouse model of Alzheimer's disease. J Magn Reson Imaging (2006) 1.13
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis. Vaccine (2011) 1.13
Predicting melanoma metastatic potential by optical and magnetic resonance imaging. Adv Exp Med Biol (2007) 1.12
Proton spin-lock ratio imaging for quantitation of glycosaminoglycans in articular cartilage. J Magn Reson Imaging (2003) 1.10
Chemical Exchange Saturation Transfer (CEST) Imaging: Description of Technique and Potential Clinical Applications. Curr Radiol Rep (2013) 1.08
CEST signal at 2ppm (CEST@2ppm) from Z-spectral fitting correlates with creatine distribution in brain tumor. NMR Biomed (2014) 1.06
Monitoring response to chemotherapy of non-Hodgkin's lymphoma xenografts by T(2)-weighted and diffusion-weighted MRI. NMR Biomed (2008) 1.04
Differentiation of infective from neoplastic brain lesions by dynamic contrast-enhanced MRI. Neuroradiology (2008) 1.04
The impact of gabapentin administration on brain GABA and glutamate concentrations: a 7T ¹H-MRS study. Neuropsychopharmacology (2012) 1.03
Indirect 17(O)-magnetic resonance imaging of cerebral blood flow in the rat. Magn Reson Med (2003) 1.03
Heterogeneity of mitochondrial redox state in premalignant pancreas in a PTEN null transgenic mouse model. Adv Exp Med Biol (2011) 1.02
A pulse sequence for rapid in vivo spin-locked MRI. J Magn Reson Imaging (2006) 1.02
Advances in Magnetic Resonance Imaging for the assessment of degenerative disc disease of the lumbar spine. Semin Spine Surg (2007) 1.01
T1rho MRI quantification of arthroscopically confirmed cartilage degeneration. Magn Reson Med (2010) 1.00
Imaging of glutamate neurotransmitter alterations in Alzheimer's disease. NMR Biomed (2012) 1.00
Imaging of glutamate in the spinal cord using GluCEST. Neuroimage (2013) 0.99
Histological basis of MR/optical imaging of human melanoma mouse xenografts spanning a range of metastatic potentials. Adv Exp Med Biol (2009) 0.99
High-resolution assessment of blood flow in murine RIF-1 tumors by monitoring uptake of H(2)(17)O with proton T(1rho)-weighted imaging. Magn Reson Med (2003) 0.99
Cartilage volume quantification via Live Wire segmentation. Acad Radiol (2004) 0.98
Characterizing the metabolic heterogeneity in human breast cancer xenografts by 3D high resolution fluorescence imaging. Springerplus (2013) 0.98
T1rho (T1ρ) MR imaging in Alzheimer's disease and Parkinson's disease with and without dementia. J Neurol (2010) 0.97
Acoustic deposition with NIMS as a high-throughput enzyme activity assay. Anal Bioanal Chem (2012) 0.96
T1rho-weighted MRI using a surface coil to transmit spin-lock pulses. J Magn Reson (2004) 0.96
Rotating frame spin lattice relaxation in a swine model of chronic, left ventricular myocardial infarction. Magn Reson Med (2010) 0.96
MICEST: a potential tool for non-invasive detection of molecular changes in Alzheimer's disease. J Neurosci Methods (2012) 0.96
T1rho contrast in functional magnetic resonance imaging. Magn Reson Med (2005) 0.95
Biomechanical and magnetic resonance characteristics of a cartilage-like equivalent generated in a suspension culture. Tissue Eng (2006) 0.94
Pulse sequence for multislice T1rho-weighted MRI. Magn Reson Med (2004) 0.94
Outcome in African-American children of neuropsychiatric lupus and lupus nephritis. Pediatr Nephrol (2002) 0.93
Ratiometric analysis in hyperpolarized NMR (I): test of the two-site exchange model and the quantification of reaction rate constants. NMR Biomed (2013) 0.93
Detection of lactate with a hadamard slice selected, selective multiple quantum coherence, chemical shift imaging sequence (HDMD-SelMQC-CSI) on a clinical MRI scanner: Application to tumors and muscle ischemia. Magn Reson Med (2009) 0.93
Estimation of the regional cerebral metabolic rate of oxygen consumption with proton detected 17O MRI during precision 17O2 inhalation in swine. J Neurosci Methods (2009) 0.93
Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model. Biomark Res (2013) 0.92
T 1 rho-relaxation mapping of human femoral-tibial cartilage in vivo. J Magn Reson Imaging (2003) 0.92
Characterization of paramagnetic effects of molecular oxygen on blood oxygenation level-dependent-modulated hyperoxic contrast studies of the human brain. Magn Reson Med (2011) 0.92
Improved bolus arrival time and arterial input function estimation for tracer kinetic analysis in DCE-MRI. J Magn Reson Imaging (2009) 0.91
Quantitative cartilage degeneration associated with spontaneous osteoarthritis in a guinea pig model. J Magn Reson Imaging (2011) 0.91
Proton MRI of metabolically produced H2 17O using an efficient 17O2 delivery system. Neuroimage (2004) 0.91
Activated intrarenal transcription of CTL-effectors and TGF-beta1 in children with focal segmental glomerulosclerosis. Kidney Int (2002) 0.90
Primary plasma cell leukemia with initial cutaneous involvement and IgA biclonal gammopathy. Ann Hematol (2007) 0.90
Fast MRI of RF heating via phase difference mapping. Magn Reson Med (2002) 0.90
Absolute cerebral blood flow quantification with pulsed arterial spin labeling during hyperoxia corrected with the simultaneous measurement of the longitudinal relaxation time of arterial blood. Magn Reson Med (2011) 0.90
Mapping glutamate in subcortical brain structures using high-resolution GluCEST MRI. NMR Biomed (2013) 0.89